Isenberg Jason 4
4 · INTELLIGENT BIO SOLUTIONS INC. · Filed Mar 20, 2026
Research Summary
AI-generated summary of this filing
Intelligent Bio Solutions (INBS) Dir. Jason Isenberg Receives Award
What Happened
Jason Isenberg, a director of Intelligent Bio Solutions, was granted 5,000 restricted shares of common stock on March 18, 2026 under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan. The Form 4 reports the grant at $0.00 per share (total $0 as reported); the award is time‑based and subject to forfeiture until it vests after 12 months.
Key Details
- Transaction date and type: 2026-03-18 — Grant/Award (code A).
- Shares and price: 5,000 restricted shares @ $0.00 (reported value).
- Vesting/forfeiture: Time‑based vesting after 12 months; shares are forfeitable until vested (Footnote F2).
- Post-reverse-split reporting: All amounts are presented post a 1-for-10 reverse split effective Dec 15, 2025 (Footnote F1).
- Shares owned after transaction: Not specified on the provided Form 4.
- Filing timeliness: Reported on 2026-03-20 for a 2026-03-18 transaction — filed within the standard 2‑business‑day window (not late).
- Plan: Issued under the 2019 Long Term Incentive Plan.
Context
This was a compensation award to a director, not an open‑market purchase or sale. Restricted stock grants are common for board compensation; the $0.00 reporting reflects grant reporting conventions on Form 4 and does not indicate market value.
Insider Transaction Report
Form 4
Isenberg Jason
Director
Transactions
- Award
Common Stock
[F2][F1]2026-03-18+5,000→ 5,000 total
Footnotes (2)
- [F1]On December 15, 2025, Intelligent Bio Solutions Inc. (the "Issuer") effected a 1-for-10 reverse stock split of the Issuer's common stock ("Common Stock"). The reverse stock split effected in December 2025, and prior reverse stock splits effected by the Issuer, resulted in a reduction in the number of shares held by the reporting person and proportional adjustments to the outstanding equity awards held by the reporting person. Accordingly, all amounts in this Form 4 are presented on a post-reverse split basis.
- [F2]On March 18, 2026, the Issuer granted the reporting person 5,000 restricted shares of Common Stock under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan. The awarded shares are subject to time-based vesting after 12 months and are subject to forfeiture until vested.
Signature
/s/ Jason Isenberg|2026-03-19